Beyond the bevacizumab resistance, combined effects of erlotinib in heavily pretreated patients with recurrent ovarian cancers.
Yoshihiro Kikuchi
No relevant relationships to disclose
Masashi Takano
No relevant relationships to disclose
Yuji Ikeda
No relevant relationships to disclose
Ryoko Kikuchi
No relevant relationships to disclose
Kazuya Kudoh
No relevant relationships to disclose
Naoki Sasaki
No relevant relationships to disclose
Masaru Sakamoto
No relevant relationships to disclose
Tsunekazu Kita
No relevant relationships to disclose
Yasuhisa Terao
No relevant relationships to disclose
Satoru Takeda
No relevant relationships to disclose